110 related articles for article (PubMed ID: 24942547)
1. Mesenchymal stromal cells uptake and release paclitaxel without reducing its anticancer activity.
Mariotti M; Colognato R; Rimoldi M; Rizzetto M; Sisto F; Cocce V; Bonomi A; Parati E; Alessandri G; Bagnati R; Pessina A
Anticancer Agents Med Chem; 2015; 15(3):400-5. PubMed ID: 24942547
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
[TBL] [Abstract][Full Text] [Related]
4. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome.
Coccè V; Bonomi A; Cavicchini L; Sisto F; Giannì A; Farronato G; Alessandri G; Petrella F; Sordi V; Parati E; Bondiolotti G; Paino F; Pessina A
Curr Cancer Drug Targets; 2020 Nov; ():. PubMed ID: 33200709
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
[TBL] [Abstract][Full Text] [Related]
9. Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.
Pessina A; Coccè V; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Navone S; Marfia G; Parati E; Alessandri G
Anticancer Agents Med Chem; 2013 Mar; 13(3):523-30. PubMed ID: 22931415
[TBL] [Abstract][Full Text] [Related]
10. Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy.
Alessandri G; Coccè V; Pastorino F; Paroni R; Dei Cas M; Restelli F; Pollo B; Gatti L; Tremolada C; Berenzi A; Parati E; Brini AT; Bondiolotti G; Ponzoni M; Pessina A
J Control Release; 2019 May; 302():2-18. PubMed ID: 30890444
[TBL] [Abstract][Full Text] [Related]
11. Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma.
Coccè V; Farronato D; Brini AT; Masia C; Giannì AB; Piovani G; Sisto F; Alessandri G; Angiero F; Pessina A
Sci Rep; 2017 Aug; 7(1):9376. PubMed ID: 28839168
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G
Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119
[TBL] [Abstract][Full Text] [Related]
13. Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.
Bonomi A; Lisini D; Navone SE; Frigerio S; Dossena M; Ciusani E; Rampini P; Marfia G; Coccè V; Cavicchini L; Sisto F; Parati E; Mantegazza R; Rimoldi M; Rizzetto M; Alessandri G; Pessina A
Cytotherapy; 2015 Mar; 17(3):310-9. PubMed ID: 25457277
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.
Brini AT; Coccè V; Ferreira LM; Giannasi C; Cossellu G; Giannì AB; Angiero F; Bonomi A; Pascucci L; Falchetti ML; Ciusani E; Bondiolotti G; Sisto F; Alessandri G; Pessina A; Farronato G
Expert Opin Drug Deliv; 2016 Jun; 13(6):789-98. PubMed ID: 26986001
[TBL] [Abstract][Full Text] [Related]
15. New Poly(3-hydroxybutyrate) Microparticles with Paclitaxel Sustained Release for Intraperitoneal Administration.
Bonartsev AP; Zernov AL; Yakovlev SG; Zharkova II; Myshkina VL; Mahina TK; Bonartseva GA; Andronova NV; Smirnova GB; Borisova JA; Kalishjan MS; Shaitan KV; Treshalina HM
Anticancer Agents Med Chem; 2017; 17(3):434-441. PubMed ID: 27141874
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.
Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; De Pascalis I; Coccè V; Bonomi A; Pascucci L; Alessandri G; Pessina A; Falchetti ML; Pallini R
Stem Cell Res Ther; 2015 Oct; 6():194. PubMed ID: 26445228
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-cancer evaluation of folic acid-peptide- paclitaxel conjugates for addressing drug resistance.
Dai Y; Cai X; Bi X; Liu C; Yue N; Zhu Y; Zhou J; Fu M; Huang W; Qian H
Eur J Med Chem; 2019 Jun; 171():104-115. PubMed ID: 30913525
[TBL] [Abstract][Full Text] [Related]
18. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.
Bonomi A; Silini A; Vertua E; Signoroni PB; Coccè V; Cavicchini L; Sisto F; Alessandri G; Pessina A; Parolini O
Stem Cell Res Ther; 2015 Aug; 6(1):155. PubMed ID: 26315881
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
[TBL] [Abstract][Full Text] [Related]
20. Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols.
Mugabe C; Liggins RT; Guan D; Manisali I; Chafeeva I; Brooks DE; Heller M; Jackson JK; Burt HM
Int J Pharm; 2011 Feb; 404(1-2):238-49. PubMed ID: 21093563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
